MedTrace Logo

Treatment of Plantar Warts

NCT05198180 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-20

No results posted yet for this study

Summary

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

Conditions

  • Plantar Wart

Interventions

DRUG

Topical 30%Potassium hydroxide solution

Patients will apply the solution every day under occlusion for 3 months

DRUG

Topical 45% hydrogen peroxide solution

Patients will apply the solution every day under occlusion

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198180 on ClinicalTrials.gov